ResMed | RMD - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
Ansell USD 231.1M 15.4M 2025-12
Artivion USD 103.68M 6.31M 2025-12
AtriCure USD 71.31M 4.66M 2026-03
Baxter International USD 1.7B 310M 2026-03
Cochlear AUD 568.4M 17.5M 2025-12
Cooper Companies USD 809.2M 2.1M 2026-03
CSL USD 4.32B 1.35B 2025-12
Dexcom USD 1.09B 182.1M 2026-03
Edwards Lifesciences USD 912.1M 19.3M 2025-12
Fisher Paykel Healthcare NZD 335.7M 16.5M 2025-12
Globus Medical USD 735.44M 8.23M 2026-03
Haemonetics USD 195.71M 11.36M 2025-12
Idexx Laboratories USD 697.21M 144.83M 2026-03
Inogen USD 37.09M 4.11M 2024-06
Insulet USD 544.7M 27.8M 2026-03
Integra LifeSciences USD 264.41M 14.44M 2026-03
Intuitive Surgical USD 1.6B 68.3M 2026-03
Medtronic USD 6.36B 30M 2025-12
Philips EUR 3.53B 273M 2026-03
Ramsay Health Care AUD 2.48B 22.3M 2025-12
ResMed USD 998.84M 13.2M 2026-03
Sigma Healthcare AUD 2.56B 2.23B 2025-12
Sonic Healthcare AUD 1.39B 23.76M 2024-12
Steris USD 1.09B 102.2M 2026-03
Teleflex USD 365.53M 19.94M 2026-03
Thermo Fisher Scientific USD 9.2B 304M 2026-03